KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill & Intangibles (2016 - 2025)

Emergent BioSolutions' Goodwill & Intangibles history spans 16 years, with the latest figure at $436.5 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 12.96% year-over-year to $436.5 million; the TTM value through Dec 2025 reached $436.5 million, down 12.96%, while the annual FY2025 figure was $436.5 million, 12.96% down from the prior year.
  • Goodwill & Intangibles reached $436.5 million in Q4 2025 per EBS's latest filing, down from $452.7 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $949.8 million in Q3 2022 to a low of $436.5 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $688.9 million, with a median of $692.2 million recorded in 2022.
  • Peak YoY movement for Goodwill & Intangibles: rose 14.17% in 2022, then tumbled 40.17% in 2023.
  • A 5-year view of Goodwill & Intangibles shows it stood at $829.5 million in 2021, then rose by 14.17% to $947.0 million in 2022, then crashed by 40.17% to $566.6 million in 2023, then fell by 11.49% to $501.5 million in 2024, then dropped by 12.96% to $436.5 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Goodwill & Intangibles are $436.5 million (Q4 2025), $452.7 million (Q3 2025), and $469.0 million (Q2 2025).